Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.850
+0.140 (8.19%)
Oct 29, 2024, 4:00 PM EDT - Market closed
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $147.77 million as of October 29, 2024. Its market cap has decreased by -20.72% in one year.
Market Cap
147.77M
Enterprise Value
86.96M
1-Year Change
-20.72%
Ranking
Category
Stock Price
$1.85
Market Cap Chart
Since October 18, 2019, Innate Pharma's market cap has decreased from $458.70M to $147.77M, a decrease of -67.78%. That is a compound annual growth rate of -20.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2024 | 138.50M | -38.55% |
| Dec 29, 2023 | 225.40M | -24.36% |
| Dec 30, 2022 | 298.00M | -17.31% |
| Dec 31, 2021 | 360.40M | 12.13% |
| Dec 31, 2020 | 321.40M | -33.19% |
| Dec 31, 2019 | 481.10M | 4.88% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tenaya Therapeutics | 154.62M |
| Repare Therapeutics | 152.38M |
| Vigil Neuroscience | 151.45M |
| Compugen | 149.53M |
| Eledon Pharmaceuticals | 148.57M |
| Nuvectis Pharma | 146.80M |
| Cardiol Therapeutics | 146.42M |
| Cardiff Oncology | 145.23M |